COMPUMEDICS LIMITED (CMP)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CMP - COMPUMEDICS LIMITED

FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: 0.32
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.265

18 Apr
2024

0.000

OPEN

$0.27

0.000

HIGH

$0.27

0

LOW

$0.27

OTHER COMPANIES IN THE SAME SECTOR
4DX . AT1 . BRN . CAT . CBL . CGS . COH . CSX . CU6 . CYC . EBR . EMV . EYE . FPH . IDX . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . VHT . VTI .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-3.5
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx42.4 M
Book Value Per Share xxxxxxxxxxxxxxx10.3
Net Operating Cash Flow xxxxxxxxxxxxxxx0.0 M
Net Profit Margin xxxxxxxxxxxxxxx-14.44 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-29.23 %
Return on Invested Capital xxxxxxxxxxxxxxx-27.94 %
Return on Assets xxxxxxxxxxxxxxx-14.77 %
Return on Equity xxxxxxxxxxxxxxx-29.23 %
Return on Total Capital xxxxxxxxxxxxxxx-12.21 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-0.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx8 M
Long Term Debt xxxxxxxxxxxxxxx2 M
Total Debt xxxxxxxxxxxxxxx9 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx4 M
Price To Book Value xxxxxxxxxxxxxxx1.74

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx4.4 M
Capex % of Sales xxxxxxxxxxxxxxx10.39 %
Cost of Goods Sold xxxxxxxxxxxxxxx21 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx25 M
Research & Development xxxxxxxxxxxxxxx5 M
Investments - Total xxxxxxxxxxxxxxx1 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

CMP STOCK CHART